David MacPherson

14PUBLICATIONS

112CO-AUTHORS

ChemotherapyPredictive and prognostic markersMolecular targetsCancer diagnosisEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jul 07, 2026

Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.

|Apr 29, 2025

The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models.

Ling Cai, Fangjiang Wu, Qinbo Zhou

|Apr 25, 2025

MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues.

Brian Freie, Ali H Ibrahim, Patrick A Carroll

|Apr 23, 2025

In vivo functional screens reveal <i>KEAP1</i> loss as a driver of chemoresistance in small cell lung cancer.

Lauren Brumage, Scott Best, Daniel S Hippe

|Oct 10, 2024

MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues.

Brian Freie, Ali H Ibrahim, Patrick A Carroll

|Apr 10, 2024

Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions.

Joseph B Hiatt, Anna-Lisa Doebley, Henry U Arnold

Pageof 3

Frequent Collaborators

Charles M Rudin

Ali H Ibrahim

Gavin Ha

Anna-Lisa Doebley

Robert N Eisenman

Arnaud Augert

A McGarry Houghton

Keith Eaton

Henry U Arnold

Hanna Liao

Frequent Collaborators

Charles M Rudin

Ali H Ibrahim

Gavin Ha

Anna-Lisa Doebley